Related Experiment Video
Updated: Aug 4, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Gender differences in mediators of left ventricular hypertrophy in dialysis patients
T Savage1, M Giles, C V Tomson
1Anthony Raine Laboratories, Bristol, UK.
Insights
Left ventricular hypertrophy (LVH) is common in dialysis patients and affects both sexes equally. However, pulse pressure is a key driver in men, while other factors influence LVH in women.
Area of Science:
- Nephrology
- Cardiology
- Hypertension
Background:
- Left ventricular hypertrophy (LVH) is a significant predictor of cardiovascular mortality in dialysis patients.
- Risk factors for LVH differ between genders in the general population.
Purpose of the Study:
- To investigate the prevalence and determinants of LVH in dialysis patients.
- To explore potential gender-specific differences in LVH development.
Main Methods:
- Studied 46 non-diabetic dialysis patients (hemodialysis and CAPD).
- Assessed 48-hour ambulatory blood pressure (BP), left ventricular mass index (LVMI) via echocardiography, and blood markers (hemoglobin, PTH, urea, electrolytes).
Main Results:
- LVH was prevalent in 72% of men and 68% of women.
- LVMI correlated with 48-hour pulse pressure, systolic BP, PTH, serum calcium, and hemoglobin.
- Multiple regression identified pulse pressure and systolic BP as significant predictors of LVMI.
- In men, pulse pressure strongly predicted LVMI, especially at night; no significant predictors were found in women.
Conclusions:
- LVH is equally prevalent in male and female dialysis patients.
- Determinants of LVH differ by gender, with pulse pressure being crucial in males.
- Unidentified factors likely play a predominant role in LVH development in female dialysis patients.
Abstract:
Left ventricular hypertrophy (LVH) is known to be a strong predictor of cardiovascular death in dialysis patients, but the mediators for its development remain to be clarified. In the non-renal population risk factors for LVH differ between the genders. We therefore studied 46 non-diabetic patients (26 male, 19 female) on maintenance hemodialysis (n = 25) or continuous ambulatory peritoneal dialysis (CAPD) (n = 20) all free from clinically evident cardiac disease, who underwent 48-hour ambulatory blood pressure (BP) monitoring, 2-D and M-mode echocardiography for left ventricular mass index (LVMI) and bloods for hemoglobin, parathyroid hormone (PTH), urea and electrolytes and liver function tests. Thirty-two out of 45 patients were taking antihypertensive drugs at the time of the study. The mean 48-hour BP was 135 +/- 19/83 +/- 13 mmHg and the mean LVMI was 144 +/- 50 g/m2. LVH (LVMI > 131 g/m2 men, > 100 g/m2 women) was present with equal frequency in both sexes: men 72% (18/25) and women 68% (13/19). Simple regression analysis showed that LVMI was correlated with 48-hour pulse pressure (r = 0.52, p < 0.00033), 48-hour systolic BP (r = 0.37, p < 0.05), PTH (r = 0.31, p < 0.04) and inversely with serum calcium (r = -0.29, p < 0.05) and hemoglobin (r = -0.33, p < 0.03). However, on multiple regression analysis pulse pressure (R2 = 28.7%), day systolic BP (R2 = 15.4%) and 48-hour systolic BP (R2 = 14.1%) were the only variables linked to LVMI. When the patients were split by gender, stepwise linear regression in the men showed a highly significant relationship between LVMI and pulse pressure (R2 = 37.1%) which was stronger at nighttime (R2 = 42.6%), but in females this was not apparent (R2 = 4.39%) and indeed no variable was linked to LVMI. Our study confirms that LVH is not only prevalent in dialysis patients but is present with equal frequency in both sexes. However the determinants of its development are different for each gender. In males pulse pressure, and therefore by implication vascular compliance, is important but in females, other unidentified factors predominate.
More Related Videos
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
08:57Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Mitral Regurgitation I: Introduction
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy III: Hypertrophic Cardiomyopathy